This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02030/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02030/identifier/pubchem-compound/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02030/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02030/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/resource/drugbank/drug/DB02030/identifier/chemspider/
n7http://linked.opendata.cz/resource/drugbank/property/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02030/identifier/chebi/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02030
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n9:DB02030 n10:DB02030
dcterms:title
Alpha-Ribazole-5'-Phosphate
adms:identifier
n4:16837 n5:207 n12:46936290 n13:46504584 n14:DB02030 n15:RBZ
n6:IUPAC-Name
n7:271B5E16-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B5E1C-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B5E1B-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B5E18-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B5E19-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B5E1A-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B5E14-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B5E15-363D-11E5-9242-09173F13E4C5 n7:271B5E12-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B5E13-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B5E22-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B5E23-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B5E1D-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B5E1E-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B5E20-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B5E1F-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B5E21-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B5E28-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B5E2A-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B5E2B-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B5E27-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B5E26-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B5E29-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B5E17-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B5E24-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B5E25-363D-11E5-9242-09173F13E4C5